Attovia Therapeutics | $105,000,000 | (May 14, 2024)
Glacis Labs | $2,000,000 | (May 14, 2024)
hexafarms | $1,403,746 | (May 14, 2024)
Certified by Founder
Lodge
Pragma Bio
start up
United States
- South San Francisco, California
- 27/03/2023
- Unknown
- $10,000,000
Pragma Bio exists to find cures for undruggable immunological disorders. We use real-world data and synthetic biology to map out multi-omic signatures associated with clinical outcomes in order to produce microbial-derived small molecules with therapeutic potential.
- Industry Biotechnology
- Website https://www.pragmabio.com/
- LinkedIn https://www.linkedin.com/company/pragmabio/
CereVasc | $70,000,000 | (May 14, 2024)
GigPig | $1,631,441 | (May 14, 2024)
Active Surfaces | $5,600,000 | (May 14, 2024)
May Health | $25,000,000 | (May 14, 2024)
ByHeart | $95,000,000 | (May 14, 2024)
tiney | $9,034,812 | (May 14, 2024)
Hexis | $2,009,680 | (May 14, 2024)
Nivoda | $30,000,000 | (May 14, 2024)
Switchboard Health | $6,500,000 | (May 14, 2024)